If antidepressants haven’t worked, or their side effects have become unbearable, it’s time for a different science.
At Foundation Medical Group, we offer Spravato® nasal spray, an FDA-approved breakthrough for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts or actions.
Spravato works differently — targeting glutamate to restore the brain connections depression disrupts. Many patients feel relief within hours to days.
Covered by major insurance plans, including Virginia Medicaid.
Esketamine treats depression by targeting glutamatergic pathways, improving communication between neurons and promoting neuroplasticity.
“Most patients describe the session as calm, even restorative.” — Foundation Medical Group clinical team
Modern psychiatry that combines science, technology, and highly personal care.
Doctors and psychiatric nurse practitioners collaborate daily on every Spravato case.
We follow a rigorous safety protocol for administering Spravato and documenting outcomes.
Enjoy a quiet relaxation room, continuous vital monitoring, and staff who stay with you start to finish.
Combine Spravato with NeuroStar® TMS, quantitative EEG brain mapping, and pharmacogenetic testing.
Dedicated coordinators manage prior authorizations, appeals, and copay assistance for commercial plans, Medicare, and Medicaid.
We stay in sync with your therapist, referring provider, or primary physician for a unified recovery plan.
Clear steps from consultation through maintenance therapy.
We review your history, medications, and medical eligibility, and then handle all insurance paperwork.
You self-administer Spravato under clinician supervision. Expect about two hours in-office for relaxation and monitoring.
Most patients attend twice weekly sessions for four weeks, tapering to weekly or less as depression remission builds.
We integrate therapy, medication adjustments, and brain-based tools for a comprehensive, sustained recovery.
We’re expanding to IV and IM ketamine to complement Spravato. These additions will offer even more flexible, rapid-acting options for patients with severe or treatment-resistant depression.
Spravato is FDA-approved and covered by most plans. We verify benefits up front.
Our care coordinators handle prior authorizations, scheduling, and follow-ups so you can start treatment quickly — often within one week of approval.
Need transportation support or documentation for leave? Our team guides you through every logistics step.
Including commercial plans and Virginia Medicaid.
You might benefit if any of the following apply:
Richmond, North Chesterfield, Midlothian, Chesterfield, Bon Air, Glen Allen, and Powhatan.
Take the first step toward feeling like yourself again. Our team will guide you through every visit, from the first consultation to maintenance care.
We serve the entire state of Virginia—including Richmond, Midlothian, Fairfax County, and Virginia Beach—through our telemedicine program.
Current clinic:
Suite 203, 11600 Busy Street
Richmond, VA 23236
Depression can feel impossible — but breakthroughs like Spravato are changing what is possible. Let us help you rediscover stability, clarity, and hope.
Serving Richmond, North Chesterfield, Midlothian, Chesterfield, Bon Air, Glen Allen, and Powhatan. 11600 Busy Street, Suite 203 · North Chesterfield, VA 23236
Depression can feel impossible — but breakthroughs like Spravato are changing what is possible. Let us help you rediscover stability, clarity, and hope.
Serving Richmond, North Chesterfield, Midlothian, Chesterfield, Bon Air, Glen Allen, and Powhatan. 11600 Busy Street, Suite 203 · North Chesterfield, VA 23236